Literature DB >> 23979215

Update on atrial fibrillation catheter ablation technologies and techniques.

Jane Dewire1, Hugh Calkins.   

Abstract

Catheter ablation of atrial fibrillation (AF) has become an important treatment method. Electrical isolation of the pulmonary veins is the cornerstone of most AF ablation procedures, and is defined by an entrance block observed on a circular multipolar electrode catheter. The safety and efficacy of AF ablation is best established in middle-aged patients with paroxysmal AF. Current guidelines recommend AF ablation with a level Ia indication in this group of patients. The long-term efficacy of AF ablation is well established in patients with paroxysmal AF, but less so in patients with longstanding persistent AF. In this population, current guidelines recommend AF ablation with a level IIb indication. The efficacy of catheter ablation in other patient populations, particularly elderly people and those with concomitant conditions, is also poorly defined. AF ablation is reasonably effective and safe at 12 months of follow-up, but recurrence of AF ≥1 year after ablation is not uncommon. Fortunately, the techniques and tools used for AF ablation continue to evolve. These developments include novel ablation catheters designed to increase safety, efficacy, and precision of the procedure, ablation strategies to target both pulmonary vein and nonpulmonary vein AF triggers, and improved imaging and electrical mapping to guide ablation procedures.

Entities:  

Mesh:

Year:  2013        PMID: 23979215     DOI: 10.1038/nrcardio.2013.121

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  158 in total

1.  Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center.

Authors:  Geoffrey Lee; Paul B Sparks; Joseph B Morton; Peter M Kistler; Jitendra K Vohra; Caroline Medi; Raphael Rosso; Andrew Teh; Karen Halloran; Jonathan M Kalman
Journal:  J Cardiovasc Electrophysiol       Date:  2010-08-19

2.  Pulmonary vein antral isolation and nonpulmonary vein trigger ablation without additional substrate modification for treating longstanding persistent atrial fibrillation.

Authors:  David Lin; David S Frankel; Erica S Zado; Edward Gerstenfeld; Sanjay Dixit; David J Callans; Michael Riley; Mathew Hutchinson; Fermin Garcia; Rupa Bala; Ralph Verdino; Joshua Cooper; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2012-04-17

Review 3.  Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review.

Authors:  Anthony G Brooks; Martin K Stiles; Julien Laborderie; Dennis H Lau; Pawel Kuklik; Nicholas J Shipp; Li-Fern Hsu; Prashanthan Sanders
Journal:  Heart Rhythm       Date:  2010-01-22       Impact factor: 6.343

4.  Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns.

Authors:  Phillip S Cuculich; Yong Wang; Bruce D Lindsay; Mitchell N Faddis; Richard B Schuessler; Ralph J Damiano; Li Li; Yoram Rudy
Journal:  Circulation       Date:  2010-09-20       Impact factor: 29.690

5.  Repeated provocation of time- and ATP-induced early pulmonary vein reconnections after pulmonary vein isolation: eliminating paroxysmal atrial fibrillation in a single procedure.

Authors:  Teiichi Yamane; Seiichiro Matsuo; Taro Date; Nicolas Lellouche; Mika Hioki; Ryosuke Narui; Keiichi Ito; Shin-ichi Tanigawa; Seigo Yamashita; Michifumi Tokuda; Hiroshi Yoshida; Keiichi Inada; Kenri Shibayama; Satoru Miyanaga; Hidekazu Miyazaki; Kunihiko Abe; Ken-ichi Sugimoto; Michihiro Yoshimura
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-08-13

6.  Frequency analysis in different types of paroxysmal atrial fibrillation.

Authors:  Yenn-Jiang Lin; Ching-Tai Tai; Tsair Kao; Han-Wen Tso; Satoshi Higa; Hsuan-Ming Tsao; Shih-Lin Chang; Ming-Hsiung Hsieh; Shih-Ann Chen
Journal:  J Am Coll Cardiol       Date:  2006-03-15       Impact factor: 24.094

7.  Clinical implications of reconnection between the left atrium and isolated pulmonary veins provoked by adenosine triphosphate after extensive encircling pulmonary vein isolation.

Authors:  Hitoshi Hachiya; Kenzo Hirao; Atsushi Takahashi; Yasutoshi Nagata; Kenji Suzuki; Shingo Maeda; Takeshi Sasaki; Mihoko Kawabata; Mitsuaki Isobe; Yoshito Iesaka
Journal:  J Cardiovasc Electrophysiol       Date:  2007-02-07

8.  Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon.

Authors:  Alexander Fürnkranz; Stefano Bordignon; Boris Schmidt; Melanie Gunawardene; Britta Schulte-Hahn; Verena Urban; Frank Bode; Bernd Nowak; Julian K R Chun
Journal:  J Cardiovasc Electrophysiol       Date:  2013-02-11

9.  "Dormant" pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation.

Authors:  Thomas Arentz; Laurent Macle; Dietrich Kalusche; Mélèze Hocini; Pierre Jais; Dipen Shah; Michel Haissaguerre
Journal:  J Cardiovasc Electrophysiol       Date:  2004-09

10.  Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation.

Authors:  Ri-Bo Tang; Jian-Zeng Dong; Xing-Peng Liu; Jun-Ping Kang; Shao-Fang Ding; Li Wang; De-Yong Long; Rong-Hui Yu; Xiao-Hui Liu; Shuang Liu; Chang-Sheng Ma
Journal:  Europace       Date:  2008-11-12       Impact factor: 5.214

View more
  21 in total

Review 1.  Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation.

Authors:  Christopher E Woods; Jeffrey Olgin
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

2.  Near-infrared spectroscopy integrated catheter for characterization of myocardial tissues: preliminary demonstrations to radiofrequency ablation therapy for atrial fibrillation.

Authors:  Rajinder P Singh-Moon; Charles C Marboe; Christine P Hendon
Journal:  Biomed Opt Express       Date:  2015-06-12       Impact factor: 3.732

Review 3.  Prophylactic arrhythmia surgery in association with congenital heart disease.

Authors:  Constantine Mavroudis; Barbara J Deal
Journal:  Transl Pediatr       Date:  2016-07

Review 4.  Mechanistic Approaches to Detect, Target, and Ablate the Drivers of Atrial Fibrillation.

Authors:  Jorge G Quintanilla; Julián Pérez-Villacastín; Nicasio Pérez-Castellano; Sandeep V Pandit; Omer Berenfeld; José Jalife; David Filgueiras-Rama
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-01

5.  Direct Pulmonary Vein Ablation With Stenosis Prevention Therapy.

Authors:  Christopher V DeSIMONE; David R Holmes; Elisa Ebrille; Faisal F Syed; Dorothy J Ladewig; Susan B Mikell; Joanne Powers; Scott H Suddendorf; Emily J Gilles; Andrew J Danielsen; David O Hodge; Suraj Kapa; Samuel J Asirvatham
Journal:  J Cardiovasc Electrophysiol       Date:  2015-08-16

6.  Validation of contrast-enhanced time-resolved magnetic resonance angiography in pre-ablation planning in patients with atrial fibrillation: comparison with traditional technique.

Authors:  Tarek Zghaib; Adeel Shahid; Chiara Pozzessere; Kristin K Porter; Linda C Chu; John Eng; Hugh Calkins; Ihab R Kamel; Saman Nazarian; Stefan L Zimmerman
Journal:  Int J Cardiovasc Imaging       Date:  2018-04-16       Impact factor: 2.357

Review 7.  Current progress of computational modeling for guiding clinical atrial fibrillation ablation.

Authors:  Zhenghong Wu; Yunlong Liu; Lv Tong; Diandian Dong; Dongdong Deng; Ling Xia
Journal:  J Zhejiang Univ Sci B       Date:  2021-10-15       Impact factor: 3.066

8.  Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation.

Authors:  Gerald V Naccarelli; Riccardo Cappato; Stefan H Hohnloser; Francis E Marchlinski; David J Wilber; Jim Xiang; Changsheng Ma; Susanne Hess; David Wyn Davies; Larry E Fields; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2014-07-09       Impact factor: 1.900

Review 9.  Better Lesion Creation And Assessment During Catheter Ablation.

Authors:  Saurabh Kumar; Chirag R Barbhaiya; Samuel Balindger; Roy M John; Laurence M Epstein; Bruce A Koplan; Usha B Tedrow; William G Stevenson; Gregory F Michaud
Journal:  J Atr Fibrillation       Date:  2015-10-31

10.  The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation.

Authors:  Sebastian Clauss; Moritz F Sinner; Stefan Kääb; Reza Wakili
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.